To examine whether STAT3 KD inhibits tumor growth in vivo and sensitizes MB tumors to cisplatin treatment, we first utilized a subcutaneous tumor xenograft model with HD-shSTAT3 and ONS-shSTAT3 cells (Figure 5F,G). This evidence concerns the gene STAT3 and neoplasm.